Hematology & Oncology

Fingerprint Dive into the research topics where Hematology & Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

    Gerber, D. E., Camidge, D. R., Morgensztern, D., Cetnar, J., Kelly, R. J., Ramalingam, S. S., Spigel, D. R., Jeong, W., Scaglioni, P. P., Zhang, S., Li, M., Weaver, D. T., Vaikus, L., Keegan, M., Horobin, J. C. & Burns, T. F., Jan 2020, In : Lung Cancer. 139, p. 60-67 8 p.

    Research output: Contribution to journalArticle

  • An evaluation of fulvestrant for the treatment of metastatic breast cancer

    Soleja, M., Raj, G. V. & Unni, N., Oct 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 15, p. 1819-1829 11 p.

    Research output: Contribution to journalArticle

  • A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR

    Al-Mayhani, T. F., Heywood, R. M., Vemireddy, V., Lathia, J. D., Piccirillo, S. G. M. & Watts, C., Jun 10 2019, In : Neuro-oncology. 21, 6, p. 719-729 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations